GIVEN DOUGLAS B 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
GIVEN DOUGLAS B
Director
Transactions
- Sale
Common Stock
2021-01-04$76.08/sh−4,000$304,320→ 119,368 total - Award
Common Stock
2021-01-01+9,500→ 123,368 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
- [F2]The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.86 to $76.26, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.